Chronic News and Research

RSS

Study on role of recorded ODLs in improving clinical care for low-weight babies: RWJF awards $480,000 grant

Researchers at Charles Drew University of Medicine and Science and UC Irvine will monitor the day-to-day health of low-birth-weight babies and their parents as part of a comprehensive initiative designed to combat chronic illnesses associated with low-weight births.

4 Mar 2010

Belatacept drug can prevent graft rejection in kidney transplant recipients

The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.

4 Mar 2010

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

A daily dose of vitamin D may just be what Chicagoans need to get through the long winter, according to researchers at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON). This nutrient lifts mood during cold weather months when days are short and more time is spent indoors.

4 Mar 2010

Negative results from latrepirdine Phase III clinical trial: Alzheimer's Association disappointed

"The Alzheimer's Association is disappointed to learn of the negative results from the Phase III clinical trial of latrepirdine (Dimebon)," said William Thies, Ph.D., Alzheimer's Association Chief Medical and Scientific Officer. "People with Alzheimer's, their families and caregivers desperately need more and better treatment options for this devastating, fatal brain disease."

4 Mar 2010

Kaiser Permanente awards $500,000 grant to Community Health Alliance of Pasadena

Kaiser Permanente announced today that it is awarding a half million dollar grant to the Community Health Alliance of Pasadena to help fund the expansion of primary health care services at the Pasadena Community Care Center for residents of the San Gabriel Valley.

4 Mar 2010

Covidien: Mallinckrodt launches Oral Transmucosal Fentanyl Citrate

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.

3 Mar 2010

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Bristol-Myers Squibb Company and Allergan, Inc. today announced a global agreement for the development and commercialization of AGN-209323, a Phase II-ready, orally administered small molecule in clinical development for neuropathic pain.

3 Mar 2010

Gene 'addiction' of leukaemia cells

An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.

3 Mar 2010

Allergan celebrates 20th anniversary of BOTOX in Canada

Twenty years ago, the first approved use of BOTOX(R) (botulinum toxin type A), a neurotoxin widely used to treat several life altering medical conditions, was granted in Canada. As part of the 20th anniversary celebrations, healthcare professionals from coast to coast reflect upon the discovery, science and evolution of a therapy that has impacted the lives of millions of patients worldwide.

3 Mar 2010

Shortage of donated blood in the U.S.: Research looks for ways to improve life-saving supply

There is typically a shortage of donated blood in the United States, and research at Case Western Reserve University is looking for ways of improving the life-saving supply.

3 Mar 2010

CBT effective in treating patients suffering from lupus and high levels of daily stress

This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index.

3 Mar 2010

athenahealth, DaVita to deliver web-based EHR and revenue cycle management service to nephrologists

athenahealth, Inc., a leading provider of internet-based business services to physician practices, and DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced a partnership to deliver an integrated, web-based electronic health record (EHR) and revenue cycle management service to nephrologists across the country.

3 Mar 2010

Engaging the Patient: New blog to allow experts outline ways to improve patient engagement

Healthcare leaders have learned that sometimes medical breakthroughs simply aren’t enough. Patients can forget up to 80% of their doctor’s instructions by the time they hit the parking lot. As a result, a lack of patient engagement creates a cascade of costs and negative outcomes ranging from readmissions, to poorly-managed chronic conditions, to medication non-adherence and more.

3 Mar 2010

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it had added five new prescription drugs to its products delivered through its national sales channels.

3 Mar 2010

Adult day health programs help senior participants maintain their health and independence

A recent study by San Francisco’s Institute on Aging documents that adult day health programs play a vital role in helping senior participants maintain their health and independence. Since the 1970s, adult day health care has been promoted as an alternative to nursing home care for seniors with chronic illness, disability, or dementia.

3 Mar 2010

FASEB President describes critical role biomedical research plays in improving public health

Federation of American Societies for Experimental Biology (FASEB) President Mark O. Lively, Ph.D., addressed a Capitol Hill audience, including congressional staff, and members of the Coalition for Health Funding today to describe the critical role biomedical research plays in improving public health.

3 Mar 2010

Pycnogenol counteracts kidney damage caused by hypertension, improves blood flow to the kidneys

An estimated one in ten adults suffers from kidney disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A leading cause of kidney disease is hypertension, which effects one out of every four U.S. adults. Chronically high blood pressure damages capillaries of the kidneys which in turn affects the organ's ability to filter waste and remove excess fluids from the body.

3 Mar 2010

Aurora Health Care establishes new clinic for treating chronic vulvar pain

It is a sensitive subject for many women. The issue is chronic vulvar pain, and it impacts one out of six women at some point in their lives. However, most women are unaware of their treatment options.

3 Mar 2010

Chronic News and Research

Study on role of recorded ODLs in improving clinical care for low-weight babies: RWJF awards $480,000 grant

Belatacept drug can prevent graft rejection in kidney transplant recipients

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

Negative results from latrepirdine Phase III clinical trial: Alzheimer's Association disappointed

Kaiser Permanente awards $500,000 grant to Community Health Alliance of Pasadena

Covidien: Mallinckrodt launches Oral Transmucosal Fentanyl Citrate

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Gene 'addiction' of leukaemia cells

Allergan celebrates 20th anniversary of BOTOX in Canada

Shortage of donated blood in the U.S.: Research looks for ways to improve life-saving supply

CBT effective in treating patients suffering from lupus and high levels of daily stress

athenahealth, DaVita to deliver web-based EHR and revenue cycle management service to nephrologists

Engaging the Patient: New blog to allow experts outline ways to improve patient engagement

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Lotus Pharmaceuticals adds five new prescription drugs to its products

Adult day health programs help senior participants maintain their health and independence

FASEB President describes critical role biomedical research plays in improving public health

Pycnogenol counteracts kidney damage caused by hypertension, improves blood flow to the kidneys

Aurora Health Care establishes new clinic for treating chronic vulvar pain

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News